Recent studies validated E2F3 as the direct target of various miRNAs, such miR-449a and miR-200b, to be involved in the abnormal proliferation and chemoresistance lung cancer [17, 23], supporting its multifacet roles in the pathological onset or progression in lung cancer. This evidence concerns the gene E2F3 and lung carcinoma.